news roundup
PAREXEL's decision to acquire ExecuPharm, a global functional service provider (FSP), is intended to address sponsors’ growing usage of combining different outsourcing models.
Tufts CSDD recently released results that the development process for new diabetes and non-diabetes endocrine drugs is riskier compared to all drug development.
advertisment
Click here and press play in our video player to watch a short video about Covance’s Xcellerate Insights collaborative workspace, making sharing and information access among project teams easier, more secure, and more efficient.
|
Clinerion’s updated Patient Recruitment System, which searches electronic health databases of hospitals to find eligible clinical trial candidates, includes a protocol library and collaboration tools.
advertisment
Read this interview with IBM company (eClinical Division), discusses risk-based monitoring (RBM) and how the company is innovating a 25-year-old manual process to enable better monitoring decisions. Learn More
|
In our latest poll, 54% of you said a clinical trial was a service, while 20% of you said it was neither. What is a clinical trial?
advertisment
Drive better outcomes with improved trial design Live Webinar: Tuesday, December 6 at 11am EST
Register now
|
|
|